A Simplified 3D-Plasma Culture Method for Generating Minimally Manipulated Autologous Equine Muscle-Derived Progenitor Cells.
Abstract: Musculoskeletal pathologies present challenges in athletic horses, often leading to functional impairment. The slow or limited regenerative capacity of bone, joint, and tendon/ligament injuries, coupled with the limitations of conventional treatments, highlights the need for innovative therapies such as ortho-biologics and mesenchymal stem/stroma cells. Traditional 2D cell culture systems with fetal bovine serum (FBS) fail to replicate the complexity of the in vivo environment, whereas 3D cultures more accurately mimic native tissue architecture and cell-cell interactions. This study describes a novel method for isolating muscle-derived progenitor cells in a 3D environment using an autologous plasma-based gel and an innovative cell retrieval solution. The cultured cells exhibit immunomodulatory effects on T lymphocytes, trilineage differentiation potential, and immunophenotypic characteristics consistent with conventional mesenchymal stem/stromal cells. This streamlined 3D culture technique offers a promising platform for generating minimally manipulated autologous cell products tailored for equine regenerative medicine. Key features • Development of a simplified autologous 3D-plasma-based culture method, eliminating the need for fetal bovine serum. • Fully autologous approach offering safer clinical potential for equine regenerative medicine. • Easy and time-efficient method suitable for researchers familiar with basic cell culture techniques.
©Copyright : © 2025 The Authors; This is an open access article under the CC BY-NC license.
Publication Date: 2025-12-05 PubMed ID: 41384097PubMed Central: PMC12689254DOI: 10.21769/BioProtoc.5526Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
- This study presents a new, simplified method for growing muscle-derived progenitor cells from horses using their own plasma in a three-dimensional culture system.
- The method avoids fetal bovine serum, better mimics the natural tissue environment, and produces cells with properties suitable for regenerative therapies in horses.
Background and Motivation
- Musculoskeletal injuries in athletic horses, such as those affecting bones, joints, tendons, and ligaments, often heal slowly or incompletely, leading to long-term functional problems.
- Conventional treatments have limitations, necessitating new therapeutic options like ortho-biologics and mesenchymal stem/stromal cell (MSC) therapies.
- Traditional cell culture methods use two-dimensional (2D) systems with fetal bovine serum (FBS), which do not replicate the complex three-dimensional (3D) environment of living tissues, possibly affecting cell behavior and therapy outcomes.
- 3D culture systems better mimic the natural cellular environment by preserving cell-cell and cell-matrix interactions, potentially improving cell functionality for regenerative medicine.
Novel Method Developed
- The researchers developed a simplified 3D culture method using a gel made from the horse’s own plasma, eliminating the need for FBS and thus reducing risks of immune reactions and contamination.
- This method is fully autologous, meaning all components come from the same horse, enhancing the safety profile for clinical use.
- The technique includes an innovative cell retrieval solution that allows for efficient extraction of cells grown in the 3D plasma gel without damaging their properties.
- The entire culture process is designed to be easy to perform and time-efficient, making it accessible for laboratories familiar with basic cell culture techniques.
Characteristics of Cultured Cells
- The muscle-derived progenitor cells grown in this 3D plasma-based system exhibit immunomodulatory effects on T lymphocytes, indicating potential to regulate immune responses beneficially.
- These cells demonstrate trilineage differentiation potential, meaning they can develop into three different types of cells (such as bone, cartilage, and fat), a hallmark of mesenchymal stem/stromal cells.
- The immunophenotypic profile (surface markers and other characteristics) of these cultured cells aligns with conventional MSCs, confirming their identity and potential utility.
Clinical and Research Implications
- This method paves the way for producing minimally manipulated autologous cell products tailored for equine regenerative medicine applications.
- Because it avoids animal serum products and uses the horse’s own biological materials, it may improve safety and reduce regulatory hurdles for clinical use in horses.
- The approach also offers researchers a practical platform to generate muscle progenitor cells in a more physiologically relevant 3D environment, potentially improving experimental models.
- Ultimately, this work could contribute to improved therapies for musculoskeletal injuries in athletic horses, enhancing recovery and performance.
Cite This Article
APA
Graide H, Duysens J, Frank T, Mouithys-Mickalad A, Niesten A, Sandersen C, Ceusters J, Serteyn D.
(2025).
A Simplified 3D-Plasma Culture Method for Generating Minimally Manipulated Autologous Equine Muscle-Derived Progenitor Cells.
Bio Protoc, 15(23), e5526.
https://doi.org/10.21769/BioProtoc.5526 Publication
Researcher Affiliations
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Department of equine clinical sciences, University of Liège, Liège, Belgium.
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Department of equine clinical sciences, University of Liège, Liège, Belgium.
- Center for Oxygen Research and Development, University of Liege, Liège, Belgium.
- Department of equine clinical sciences, University of Liège, Liège, Belgium.
Conflict of Interest Statement
Competing interestsD. Serteyn and J. Ceusters are the co-inventors of a patent related to muscle-derived stem cells. This patent is licensed by the University of Liège to Revatis, a Spin-Off company where D. Serteyn and J. Ceusters serve as scientific advisors. The other co-authors declare no conflicts of interest.
References
This article includes 21 references
- Jönsson L., Näsholm A., Roepstorff L., Egenvall A., Dalin G. and Philipsson J.(2013). Genetic analysis of clinical findings at health examinations of young Swedish warmblood riding horses. Acta Vet Scand. 55(1): e1186/1751–0147–55–22. 10.1186/1751-0147-55-22
- Ribitsch I., Oreff G. L. and Jenner F.(2021). Regenerative Medicine for Equine Musculoskeletal Diseases. Animals. 11(1): 234 10.3390/ani11010234
- Ireland J. L., McGowan C. M., Clegg P. D., Chandler K. J. and Pinchbeck G. L.(2012). A survey of health care and disease in geriatric horses aged 30years or older. Vet J. 192(1): 57 64 64. 10.1016/j.tvjl.2011.03.021
- van Weeren P. R. and Back W.(2016). Musculoskeletal Disease in Aged Horses and Its Management. Vet Clin N Am: Equine Pract. 32(2): 229 247 247. 10.1016/j.cveq.2016.04.003
- Wright I., Minshall G., Young N. and Riggs C.(2024). Fractures in Thoroughbred racing and the potential for pre‐race identification of horses at risk. Equine Vet J. 56(3): 424 436 436. 10.1111/evj.14046
- Bertuglia A., Bullone M., Rossotto F. and Gasparini M.(2014). Epidemiology of musculoskeletal injuries in a population of harness Standardbred racehorses in training. BMC Vet Res. 10(1): 11 10.1186/1746-6148-10-11
- Sousa B. R., Parreira R. C., Fonseca E. A., Amaya M. J., Tonelli F. M. P., Lacerda S. M. S. N., Lalwani P., Santos A. K., Gomes K. N., Ulrich H., et al.(2013). Human adult stem cells from diverse origins: An overview from multiparametric immunophenotyping to clinical applications. Cytometry Part A. 85(1): 43 77 77. 10.1002/cyto.a .22402
- Shammaa R., El-Kadiry A. H., Abusarah J. and Rafei M.(2020). Mesenchymal Stem Cells Beyond Regenerative Medicine. Front Cell Dev Biol. 8: e00072. 10.3389/fcell.2020 .00072
- Geburek F., Gaus M., van Schie H. T. M., Rohn K. and Stadler P. M.(2016). Effect of intralesional platelet-rich plasma(PRP) treatment on clinical and ultrasonographic parameters in equine naturally occurring superficial digital flexor tendinopathies– a randomized prospective controlled clinical trial. BMC Vet Res. 12(1): e1186/s12917–016–0826–1. 10.1186/s12917-016-0826-1
- Frisbie D. D., Kawcak C. E., Werpy N. M., Park R. D. and McIlwraith C. W.(2007). Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res. 68(3): 290 296 296. 10.2460/ajvr.68 .3.290
- Bertone A. L., Ishihara A., Zekas L. J., Wellman M. L., Lewis K. B., Schwarze R. A., Barnaba A. R., Schmall M. L., Kanter P. M., Genovese R. L., et al.(2014). Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses. Am J Vet Res. 75(2): 141 151 151. 10.2460/ajvr.75.2.141
- Renzi S., Riccò S., Dotti S., Sesso L., Grolli S., Cornali M., Carlin S., Patruno M., Cinotti S., Ferrari M., et al.(2013). Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: A clinical report. Res Vet Sci. 95(1): 272 277 277. 10.1016/j.rvsc.2013.01.017
- Stewart A. A., Barrett J. G., Byron C. R., Yates A. C., Durgam S. S., Evans R. B. and Stewart M. C.(2009). Comparison of equine tendon-, muscle-, and bone marrow–derived cells cultured on tendon matrix. Am J Vet Res. 70(6): 750 757 757. 10.2460/ajvr.70.6.750
- Lecourt S., Marolleau J. P., Fromigué O., Vauchez K., Andriamanalijaona R., Ternaux B., Lacassagne M. N., Robert I., Boumédiene K., Chéreau F., et al.(2010). Characterization of distinct mesenchymal-like cell populations from human skeletal muscle in situ and in vitro. Exp Cell Res. 316(15): 2513 2526 2526. 10.1016/j.yexcr.2010.04.020
- Kisiel A. H., McDuffee L. A., Masaoud E., Bailey T. R., Esparza Gonzalez B. P. and Nino-Fong R.(2012). Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum. Am J Vet Res. 73(8): 1305 1317 1317. 10.2460/ajvr.73.8.1305
- Radtke C. L., Nino-Fong R., Esparza Gonzalez B. P., Stryhn H. and McDuffee L. A.(2013). Characterization and osteogenic potential of equine muscle tissue– and periosteal tissue–derived mesenchymal stem cells in comparison with bone marrow– and adipose tissue–derived mesenchymal stem cells. Am J Vet Res. 74(5): 790 800 800. 10.2460/ajvr.74.5.790
- Ceusters J., Lejeune J. P., Sandersen C., Niesten A., Lagneaux L. and Serteyn D.(2017). From skeletal muscle to stem cells: an innovative and minimally-invasive process for multiple species. Sci Rep. 7(1): e1038/s41598–017–00803–7. 10.1038/s41598-017-00803-7
- Fontoura J. C., Viezzer C., dos Santos F. G., Ligabue R. A., Weinlich R., Puga R. D., Antonow D., Severino P. and Bonorino C.(2020). Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance. Materials Science and Engineering: C. 107: 110264 10.1016/j.msec.2019.110264
- Antoni D., Burckel H., Josset E. and Noel G.(2015). Three-Dimensional Cell Culture: A Breakthrough in Vivo. Int J Mol Sci. 16(3): 5517 5527 5527. 10.3390/ijms16035517
- Centeno E. G. Z., Cimarosti H. and Bithell A.(2018). 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling. Mol Neurodegener. 13(1): e1186/s13024–018–0258–4. 10.1186/s13024-018-0258-4
- Duysens J., Graide H., Niesten A., Mouithys-Mickalad A., Deby-Dupont G., Franck T., Ceusters J. and Serteyn D.(2024). Culture and Immunomodulation of Equine Muscle-Derived Mesenchymal Stromal Cells: A Comparative Study of Innovative 2D versus 3D Models Using Equine Platelet Lysate. Cells. 13(15): 1290 10.3390/cells13151290
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
